The Year 2022 in Cardiovascular Diseases-Clinics and Practice

Abrignani MG
Clinics and practice · 2023 · vol. 13(4) , pp. 763–767 · doi:10.3390/clinpract13040069 · PMID:37489418 · PMC10366779
Other OA: gold CC-BY-4.0
📄 Open PDF View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-09-30 ⓘ

The provided abstract describes the journal Cardiovascular Diseases-Clinics and Practice achieving its first impact factor in 2022, without mentioning endometriosis or adenomyosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

This journal has recently achieved significant milestones, receiving its first impact factor of 2 [...].

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-11-01T09:25:17.647243+00:00
pubmed
last seen: 2026-10-08T21:40:42.408062+00:00
License: CC-BY-4.0 · commercial use OK · attribution required
Per Europe PMC